Fluorapacin
Alternative Names: BFBTS; FLPLatest Information Update: 13 Apr 2021
At a glance
- Originator ACEA Biosciences
- Class Antineoplastics; Fluorobenzenes; Sulfides
- Mechanism of Action Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Lung cancer; Solid tumours
Most Recent Events
- 20 Apr 2016 Chemical structure information added
- 20 Apr 2016 No recent reports on development identified - Phase-I for Solid tumours & Lung cancer (Late-stage disease) in China (IV)
- 24 May 2011 Phase-I clinical trials in Solid tumours and Lung cancer (late-stage) in China (IV)